Deerfield Mgmt Reports 2.2M Share Stake in Solid Biosciences

TL;DR

**Deerfield just bought 2.2M shares of Solid Biosciences, signaling big institutional interest.**

AI Summary

Deerfield Mgmt, L.P., a Delaware-based investment firm, reported beneficial ownership of 2,200,000 shares of Solid Biosciences Inc. (NASDAQ: SLDB) Common Stock as of January 11, 2024. This filing, an SC 13G, indicates that Deerfield now holds a significant stake in the company, potentially signaling their confidence in Solid Biosciences' future prospects. This matters to investors because a large institutional investment can influence stock price and company strategy, suggesting a vote of confidence from a sophisticated investor.

Why It Matters

A major institutional investor like Deerfield Mgmt taking a significant stake can be seen as a positive signal, potentially attracting other investors and influencing the stock's performance.

Risk Assessment

Risk Level: low — This filing indicates an institutional investment, which is generally a positive or neutral event for existing shareholders.

Analyst Insight

A smart investor would research Deerfield Management's investment thesis and Solid Biosciences' fundamentals to understand the potential implications of this significant institutional stake, considering it a positive signal for the stock.

Key Numbers

• 2,200,000 — Shares Beneficially Owned (Number of Common Stock shares of Solid Biosciences Inc. owned by Deerfield Mgmt, L.P.)
• January 11, 2024 — Date of Event (The date that triggered the requirement for this SC 13G filing.)
• 83422E204 — CUSIP Number (Unique identification number for Solid Biosciences Inc. Common Stock.)

Key Players & Entities

• Deerfield Management Company, L.P. (company) — reporting person and investment firm
• Solid Biosciences Inc. (company) — subject company, issuer of the stock
• Flynn James E (person) — filer of the SC 13G
• Delaware (company) — place of organization for Deerfield Mgmt, L.P.

Forward-Looking Statements

• Solid Biosciences Inc. stock price may see increased investor interest due to this institutional filing. (Solid Biosciences Inc.) — medium confidence, target: Within the next 3 months

FAQ

Filing Documents

• e619187_sc13g-sb.htm (SC 13G) — 99KB
• 0001193805-24-000044.txt ( ) — 100KB

(a)

Item 1(a). Name of Issuer: Solid Biosciences Inc.

(b)

Item 1(b). Address of Issuer's Principal Executive Offices: 500 Rutherford Avenue, Third Floor Charlestown, MA 02129

(a)

Item 2(a). Name of Person Filing: James E. Flynn, Deerfield Mgmt, L.P., Deerfield Management Company, L.P. and Deerfield Partners, L.P.

(b)

Item 2(b). Address of Principal Business Office, or if None, Residence: James E. Flynn, Deerfield Mgmt, L.P., Deerfield Management Company, L.P. and Deerfield Partners, L.P., 345 Park Avenue South, 12th Floor, New York, NY 10010

(c)

Item 2(c). Citizenship: Deerfield Mgmt, L.P., Deerfield Management Company, L.P. and Deerfield Partners, L.P. - Delaware limited partnerships; James E. Flynn – United States citizen

(d)

Item 2(d). Title of Class of Securities: Common Stock

(e)

Item 2(e). CUSIP Number: 83422E204 Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: (a) Broker or dealer registered under Section 15 of the Exchange Act. (b) Bank as defined in Section 3(a)(6) of the Exchange Act. (c) Insurance company as defined in Section 3(a)(19) of the Exchange Act. (d) Investment company registered under Section 8 of the Investment Company Act. (e) An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); (h) A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; (i) A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act; CUSIP No. 83422E204 13G Page 7 of 9 (j) A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J); (k) Group, in accordance with Rule 13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please specify the type of institution: ___________________________________________ Item 4. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned**: Deerfield Mgmt, L.P. – 2,260,398 shares Deerfield Management Company, L.P. - 2,260,398 shares Deerfield Partners, L.P. - 2,260,398 shares James E. Flynn – 2,260,398 shares (b) Percent of class**: Deerfield Mgmt, L.P. – 6.08% Deerfield Management Company, L.P. – 6.08% Deerfield Partners, L.P. – 6.08% James E. Flynn – 6.08% (c) Number of shares as to which such person has**: (i) Sole power to vote or to direct the vote: All Reporting Persons - 0

View Full Filing

View this SC 13G filing on SEC EDGAR